AAAAAA
Results: 1-25/289
Authors:
BEHR TM
WORMANN B
GRATZ S
HOLLER E
KOLB HJ
HIDDEMANN W
GOLDENBERG DM
BECKER W
Citation: Tm. Behr et al., 36TH INTERNATIONAL ANNUAL-MEETING OF THE GERMAN-SOCIETY-FOR-NUCLEAR-MEDICINE, Nuklearmedizin, 37(2), 1998, pp. 4-101
Authors:
HIDDEMANN W
GRIESINGER F
UNTERHALT M
Citation: W. Hiddemann et al., INTERFERON-ALPHA FOR THE TREATMENT OF FOLLICULAR LYMPHOMAS, The cancer journal from Scientific American, 4, 1998, pp. 13-18
Authors:
BERTRAM J
PALFNER K
HIDDEMANN W
KNEBA M
Citation: J. Bertram et al., OVEREXPRESSION OF RIBOSOMAL-PROTEINS L4 AND L5 AND THE PUTATIVE ALTERNATIVE ELONGATION-FACTOR PTI-1 IN THE DOXORUBICIN-RESISTANT HUMAN COLON-CANCER CELL-LINE LOVODX(R), European journal of cancer, 34(5), 1998, pp. 731-736
Authors:
BERTRAM J
PALFNER K
HIDDEMANN W
KNEBA M
Citation: J. Bertram et al., ELEVATED EXPRESSION OF S100P, CAPL AND MAGE-3 IN DOXORUBICIN-RESISTANT CELL-LINES - COMPARISON OF MESSENGER-RNA DIFFERENTIAL DISPLAY REVERSE TRANSCRIPTION-POLYMERASE CHAIN-REACTION AND SUBTRACTIVE SUPPRESSIVE HYBRIDIZATION FOR THE ANALYSIS OF DIFFERENTIAL GENE-EXPRESSION, Anti-cancer drugs, 9(4), 1998, pp. 311-317
Authors:
KERN W
AUL C
MASCHMEYER G
KUSE R
KERKHOFF A
GROTEMETKE A
EIMERMACHER H
KUBICA U
WORMANN B
BUCHNER T
HIDDEMANN W
Citation: W. Kern et al., GRANULOCYTE-COLONY-STIMULATING FACTOR SHORTENS DURATION OF CRITICAL NEUTROPENIA AND PROLONGS DISEASE-FREE SURVIVAL AFTER SEQUENTIAL HIGH-DOSE CYTOSINE-ARABINOSIDE AND MITOXANTRONE (S-HAM) SALVAGE THERAPY FOR REFRACTORY AND RELAPSED ACUTE MYELOID-LEUKEMIA, Annals of hematology, 77(3), 1998, pp. 115-122
Authors:
WULF GG
JAHNSSTREUBEL G
HEMMERLEIN B
BONNEKESSEN K
WORMANN B
HIDDEMANN W
Citation: Gg. Wulf et al., PLASMACYTOSIS IN ACUTE MYELOID-LEUKEMIA - 2 CASES OF PLASMACYTOSIS AND INCREASED IL-6 PRODUCTION IN THE AML BLAST CELLS, Annals of hematology, 76(6), 1998, pp. 273-277
Authors:
KERN W
BRAESS J
BERTZ H
POTT C
SCHLEYER E
FINKE J
RUCHEL R
HIDDEMANN W
Citation: W. Kern et al., CHRONIC SYSTEMIC ASPERGILLOSIS IN A PATIENT WITH ACUTE MYELOID-LEUKEMIA, Annals of hematology, 76(3-4), 1998, pp. 175-177
Authors:
BEHRE G
LINK H
MASCHMEYER G
MEYER P
PAAZ U
WILHELM M
HIDDEMANN W
Citation: G. Behre et al., MEROPENEM MONOTHERAPY VERSUS COMBINATION THERAPY WITH CEFTAZIDIME ANDAMIKACIN FOR EMPIRICAL-TREATMENT OF FEBRILE NEUTROPENIC PATIENTS, Annals of hematology, 76(2), 1998, pp. 73-80
Authors:
HIDDEMANN W
Citation: W. Hiddemann, MANTLE CELL LYMPHOMAS, Annals of oncology, 9, 1998, pp. 10-10
Authors:
GRIESINGER F
HANNEMANN P
CRIEE CP
HEMMERLEIN B
DALICHAU H
HESS CF
WORMANN B
SCHMIDBERGER H
HERSE B
HIDDEMANN W
Citation: F. Griesinger et al., STAGE IIIB NONSMALL CELL LUNG-CANCER - TAXANE CARBOPLATIN (T/C) COMBINATION THERAPY FOR INDUCTION/, Annals of oncology, 9, 1998, pp. 489-489
Authors:
BRUHN T
HIDDEMANN W
KNEBA M
BERTRAM J
Citation: T. Bruhn et al., HAMMERHEAD RIBOZYMES TO REDUCE THYMIDYLATE SYNTHASE OVEREXPRESSION, Annals of oncology, 9, 1998, pp. 585-585
Authors:
KERN W
AUL C
MASCHMEYER G
SCHONROCKNABULSI R
LUDWIG WD
BARTHOLOMAUS A
BETTELHEIM P
WORMANN B
BUCHNER T
HIDDEMANN W
Citation: W. Kern et al., SUPERIORITY OF HIGH-DOSE OVER INTERMEDIATE-DOSE CYTOSINE-ARABINOSIDE IN THE TREATMENT OF PATIENTS WITH HIGH-RISK ACUTE MYELOID-LEUKEMIA - RESULTS OF AN AGE-ADJUSTED PROSPECTIVE RANDOMIZED COMPARISON, Leukemia, 12(7), 1998, pp. 1049-1055
Authors:
RITTERBACH J
HIDDEMANN W
BECK JD
SCHRAPPE M
JANKASCHAUB G
LUDWIG WD
HARBOTT J
LAMPERT F
Citation: J. Ritterbach et al., DETECTION OF HYPERDIPLOID KARYOTYPES (GREATER-THAN-50 CHROMOSOMES) INCHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) USING FLUORESCENCE IN-SITU HYBRIDIZATION (FISH), Leukemia, 12(3), 1998, pp. 427-433
Authors:
KERN W
BRAESS J
GROTEMETKE A
KUSE H
FUCHS R
HOSSFELD DK
REICHLE A
WORMANN B
BUCHNER T
HIDDEMANN W
Citation: W. Kern et al., COMBINATION OF ACLARUBICIN AND ETOPOSIDE FOR THE TREATMENT OF ADVANCED ACUTE MYELOID-LEUKEMIA - RESULTS OF A PROSPECTIVE MULTICENTER PHASE-II TRIAL, Leukemia, 12(10), 1998, pp. 1522-1526
Authors:
BRAESS J
FREUND M
HANAUSKE A
HEIL G
KAUFMANN C
KERN W
SCHUSSLER M
HIDDEMANN W
SCHLEYER E
Citation: J. Braess et al., ORAL CYTARABINE OCFOSFATE IN ACUTE MYELOID-LEUKEMIA AND NON-HODGKINS-LYMPHOMA - PHASE I II STUDIES AND PHARMACOKINETICS/, Leukemia, 12(10), 1998, pp. 1618-1626
Authors:
POTT C
TIEMANN M
LINKE B
OTT MM
VONHOFEN M
BOLZ I
HIDDEMANN W
PARWARESCH R
KNEBA M
Citation: C. Pott et al., STRUCTURE OF BCL-1 AND IGH-CDR3 REARRANGEMENTS AS CLONAL MARKERS IN MANTLE CELL LYMPHOMAS, Leukemia, 12(10), 1998, pp. 1630-1637
Authors:
SORURI A
WORMANN B
HAFERLACH T
HIDDEMANN W
PETERS JH
Citation: A. Soruri et al., DENDRITIC CELL-DIFFERENTIATION PATHWAY INDUCED IN ACUTE MYELOID-LEUKEMIA CELLS, Journal of leukocyte biology, 1998, pp. 13-13
Authors:
SORURI A
WORMANN B
HAFERLACH T
HIDDEMANN W
PETERS JH
Citation: A. Soruri et al., DENDRITIC CELL-DIFFERENTIATION PATHWAY INDUCED IN ACUTE MYELOID-LEUKEMIA CELLS, Journal of leukocyte biology, 1998, pp. 38-38
Authors:
HIDDEMANN W
UNTERHALT M
HERMANN R
WOLTJEN HH
KREUSER ED
TRUMPER L
REUSSBORST M
TERHARDTKASTEN E
BUSCH M
NEUBAUER A
KAISER U
HANRATH RD
MIDDEKE H
HELM G
FREUND M
STEIN H
TIEMANN M
PARWARESCH R
Citation: W. Hiddemann et al., MANTLE-CELL LYMPHOMAS HAVE MORE WIDESPREAD DISEASE AND A SLOWER RESPONSE TO CHEMOTHERAPY COMPARED WITH FOLLICLE-CENTER LYMPHOMAS - RESULTS OF A PROSPECTIVE COMPARATIVE-ANALYSIS OF THE GERMAN LOW-GRADE LYMPHOMASTUDY-GROUP, Journal of clinical oncology, 16(5), 1998, pp. 1922-1930
Authors:
KOHNE CH
SCHOFFSKI P
WILKE H
KAUFER C
ANDREESEN R
OHL U
KLAASEN U
WESTERHAUSEN M
HIDDEMANN W
SCHOTT G
HARSTICK A
BADE J
HORSTER A
SCHUBERT U
HECKER H
DORKEN B
SCHMOLL HJ
Citation: Ch. Kohne et al., EFFECTIVE BIOMODULATION BY LEUCOVORIN OF HIGH-DOSE INFUSION FLUOROURACIL GIVEN AS A WEEKLY 24-HOUR INFUSION - RESULTS OF A RANDOMIZED TRIALIN PATIENTS WITH ADVANCED COLORECTAL-CANCER, Journal of clinical oncology, 16(2), 1998, pp. 418-426
Authors:
WULF GG
REICHARD U
WORMANN B
HIDDEMANN W
Citation: Gg. Wulf et al., PNEUMOCYSTIS-CARINII PNEUMONIA WITH PERIPHERAL NODULAR INFILTRATES INA PATIENT WITH T-ACUTE LYMPHOBLASTIC-LEUKEMIA, Journal of clinical oncology, 16(10), 1998, pp. 3476-3477
Authors:
WORMANN B
WULF G
HIDDEMANN W
Citation: B. Wormann et al., CLINICAL RESEARCH IN ONCOLOGY - RELEVANCE DESIGN, ETHICAL CONSIDERATIONS, Medizinische Klinik, 93(3), 1998, pp. 181-189
Authors:
HANNIG H
BUSKE C
REDDERSEN S
WILHELM C
HIDDEMANN W
WORMANN B
Citation: H. Hannig et al., TGF-BETA IS A GROWTH-REGULATORY CYTOKINE IN LOW-GRADE B-NON-HODGKINS LYMPHOMA (B-NHL), Experimental hematology, 26(8), 1998, pp. 383-383
Authors:
FEURINGBUSKE M
HAASE D
HIDDEMANN W
WORMANN B
Citation: M. Feuringbuske et al., PERSISTENT LEUKEMIA IN THE CD34-CELL COMPARTMENT IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA IN MORPHOLOGICAL COMPLETE REMISSION( STEM), Experimental hematology, 26(8), 1998, pp. 388-388
Authors:
BUSKE C
BECKER D
FEURINGBUSKE M
HANNIG H
GRIESINGER F
HIDDEMANN W
WORMANN B
Citation: C. Buske et al., TGF-BETA AND ITS RECEPTOR COMPLEX IN LEUKEMIC B-CELL PRECURSORS, Experimental hematology, 26(12), 1998, pp. 1155-1161